Jonathan B. Rome Named COO of Boston Therapeutics, Inc. (BTHE)

Jonathan B. Rome Named COO of Boston Therapeutics, Inc. (BTHE)

Yesterday, Boston Therapeutics announced that Mr. Jonathan B. Rome has been named as its Chief Operating Officer.

David Platt, Ph.D., Boston?s CEO, remarked, ?Jonathan Rome has more than 30 years? experience and success in the sales, marketing and distribution of pharmaceutical products and developing collaborations around the world. Jonathan is an excellent choice to commercialize SUGARDOWN? and to lead the filing of an ANDA to market BTI-7.?

Mr. Rome was the Founder, President, and CEO of ThePharmaNetwork, LLC, which was focused on pharmaceutical portfolio development, licensing, sales, marketing, and distribution of pharmaceuticals and APIs as well as sales, marketing, and distribution of finished products under the Ascend Laboratories, LLC label to all major U.S. customers. Mr. Rome was also a founder of Beijing-based AlliancePharm LLC, a founder of Shanghai-based TPN China, Inc., and a founder of Rome, Italy-based TPN Italia. Mr. Rome specializes in collaborations, global supply chain, sales and marketing, licensing, and has extensive outsourcing experience through a network that spans five continents.

?I am excited about joining Boston Therapeutics,? said Jonathan Rome. ?The elements for success are here: excellent complex carbohydrate chemistry, products to address unmet medical needs in a very large diabetes market worldwide and a talented and dedicated team. I am confident we can be successful and take the Company to the next level.?

Mr. Rome will be in charge of accelerating the commercialization of SUGARDOWN? and filing an Abbreviated New Drug Application (?ANDA?) for BTI-7, a new chewable dosage form of the diabetes drug metformin hydrochloride. SUGARDOWN? is a non-systemic chewable dietary supplement tablet that controls post-meal blood glucose.

For more information on Boston Therapeutics, visit www.bostonti.com

About QualityStocks
?
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
?
Sign up for ?The QualityStocks Daily Newsletter? at www.QualityStocks.net
?
The QualityStocks Daily Blog http://blog.qualitystocks.net
?
The QualityStocks Video Charts http://videocharts.qualitystocks.net
?
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Source: http://www.smallcapnetwork.com/Jonathan-B-Rome-Named-COO-of-Boston-Therapeutics-Inc-BTHE/s/via/19046/blog/view/p/mid/1/id/119/

mitch hedberg secret service scandal shea weber greystone sidney crosby at the drive in alternative minimum tax